Platelets from a plateler factor 3-deficient patient, which sure of negativaly charged phospholipid at the outer eurwas first described by Weiss et al (Am J Mad 67:2A6, face of the patient's platelets, relative to control's. We I 9791, were found to be equally impaired in their ability to suggest ihat the combined impairment o{ prothrombin-and promot€ factor X and prothrombin activation. Compared to factor X-converting activities in this patient is due to a normal plstolets, the patient's platelets showed upon stimdefaqt in the mechanism by which phosphatidyltcrine ulation with thrombin plus collagen a much slower gonerabecomes exposed at the outer sorface of stimulatcd platotion rnd a considerably lower level of plstolot prothrombinlets, and factor X-convening activities. Treatment of stimulated o 1985 by Grune & Stratton, lnc. platelete with phospholipases rovealed a decreased cxpo-TTORMATION of a hemostatic plug at sites of t' vascular injury rcquires concerted action of blood platelets and plasma coagulation facrors. Plarelers contribute to the arrest of bleeding by clumping together into aggregates and by promoring efficient coagulation, which consolidates the platelet plug u'irh strands of fibrin. Apart frop their parriciparion in rhe contact system of coagulation, platelers promote conversion of factor X to Xa and of prothrombin to thrombin in the presence of other coagularion factors.r'2 Since both reactions are stimulated in vitro by negativel), charged phospholipids, the procoagulant property of platelers has been partl.r' attributed ro membrane lipid or lipoprotein which becomes exposed upon platelet activation.lr Miletich et al5 have shown that thronibin-activated platelets can bind factor Xa and that the binding sitc for factor Xa is associated with platelet-bound factor Va. Interestingly, they demonstrated that platelets from a patient with an isolared deficiency of platelet procoagulant activit)', earlier described by Weiss et aJ,6 had a reduced number of factor Xa-factor Va binding sites.T Impaired binding was shown to be reflected in a reduced ability of these platelets to enhance conversion of prothrombin to thrombin by factors Xa, Va, and calcium. Since the patient's platelet factor Va activity released after thrombin treatment is normal. Miletich et alr concluded that an as yet unidentified membrane mmponent essential for thrombin formation at the platelet surface is deficient in these platelets. Because the chemical nature of this component does not necessarill' havc to be phospholipid, it was of interest to see whether or not the platelets of this patient are able to enhance the other lipid-dependent coagulation reaction, ie, conversion of factor X to Xa by factors IXa, VIIIa, and calcium.
In this study, we report that these platelets are cqually impqired in their ability to promote factor Xa and thrombin formation. In addition, we provide evidence that exposure of negatively charged phospholip ids at the outer surface of activated platelets'is substantially lower in this patient rhan observed with normal platelets.
MATERIALS AND METHODS

Plat e lets
Washed platelets wcre prepared as describcd prcviouslv.. Thc patienr M.S.. wirh a moderatcly sevcrc blccding disordcr, has be*n rcporred in dcrail b1, Weiss et al.6 Shc visired Maastricht for rhcsc studies and blood u,as taken from hcr on thrcc occasions at thc samc time as control's. Measuremcnts of plarclct activity in prothrombin and factor X acrivation, as wcll as platclct trcatment with cxogcnous phospholipases. wcrc conductcd within a pcriod of t8 houn aficr vcnipuncturc. Platclct conccntration was dctermincd with a Coulrcr Counter (Hialcah, Fla). Paticnr's platclcrs and controt's wcrc adjustcd to the samc count.
Proteins
Coagulation factors VIIIC, IX, Xr. V, and prothrombin wcrc purified from bovinc blood according ro astablishcd proccdurcs as dcscribcd clsewhcrc.r-ro Factors VIIIa, IXa, Xa, Va. and thrombin wcrc prcparcd from rheir rcspcctive prccursors.r.t Molar conccntra. tions of coagulation factors werc dctcrmincd by activc sitc titration or by kinctic analysis.r0 Phospholipasc A, (phospbatidc-2-acylhydro lase: EC 3. I . I .4) from Naja naja znd bee venom and sphingomyelinase (sphingomyelin-cholinephosphohydrolasc: EC 3. 1.4. I 2) from Sraphylococcus aureus were purified as describcd bcforc.rr One intcrnarional unit of phospholipase is dcfincd as thc amount of 1558.
cnz!'mc chich hydrol!zes I rmol of phospholipid per minute under oprimal conditions. Assavs Prorhrombin-and factor X'converting activitics of platclets were calculatcd from thc ralcs of thrombin and factor Xa formation detcrmincd u'ith chromogcnic substratcs.r0 ln some cxperiments' platclet prothrombinasc acrivily \r'as mcasurcd in the absence of ,dd.d f.",ot \ra. Incubation of (activarcd) platelcts u'ith phospholi' pascs followcd by lipid cxtraction and dctermination of surface' cxposed phospholipids u'as pcrformcd in thc samc wav as describcd clscwhcrc.'
RESULTS
Plareler Prothrombinase Activity Without Addition of Factor Va
Miletich et alt showed that the patient's platelets stimulated b1'thrombin had normal factor Va activity' Addition of factor Xa and prothrombin to these platelets resulted. however. in thrombin Seneration rates that were about three times lower than normal'' Figure  I shoq,s that similar results were obtained in our laborarorl' using a chromogenic substrate assa)' to measure tates of thrombin formation' Platelets were activated b;' thrombin and the tine course of genera' tion of platelet prothrombinase aclivit)' u'as measurcd in the absence of added factor Va' At final concentra' tions of 0.2 nmol/L facror Xa and 4 pmol/L prothrom' bin. the Patienr's platelets showed rates of thrombin formation which were about half of those observed u'ith normal platelets. The factor Xa concentration emDlciv(d was similar to that used in the abovementioned study' (5 ng Xa/mL) and approximated the reported dissociation cons[ant of factor Xa for thrombin-activated platelets (-0-l nmol/L)'5r
We have previously shou'n that stimulation b;" collagen plus thrombin makes platelets much. more active in prorhrombin acrivation (as well as in factor X .
RCSING ET AL activation ) than stimulation b1' either collagcn or thrombin separately.'o Figure I shows that this effecr is also apparent in the absence of added factor Va. Despite the fact that the same factor Va activities were present in platelets stimulated by thrombin or b1' , collagen plus thrombin, the latter activation procedure resulrs in much higher prothrombin-converting act.ivities. Nevertheless, collagen plus thrombin stimulated piatelets from patient M.S. remain about 2t/: times less active than stimulated control plateleuContparison Between Platelet-Enhanced Factor X and Prot h rombf n Activat ion
The abnormal prothrombinase activity of platelets from patient M.S. has been ascribed to a Partial deficiency of specific factor Xa-factor Va binding sitcs on the platelets.t't The next experimcnts rvcre designed to determine whether this deficiency is limitcd to prorhrombinase activitv or also affects the factor X-converting activit!' of thcse platelets. Both coagu' lanr reactions were measured with added factors Xa. Va. and prothrombin, or factors V!Ila-IXa, and X. respectivel\'. For prothrombinase mcasurements, setu' rating amounts of factor Va u'ere addcd to make prothrombin activation independent of release and acrivation of platelet factor V. On stimulation of platelets from patient M.S' with collagen plus throm' tin. Uottr rhe development of prothrombinase activit)' and factor X converring activity u'ere considerabl'v lcss rhan observed u'ith normal platelets (Fig 2) ' Tcn min' utes afler platelet stimulation, both activities were about 257o ro 30Vc of that of normal platelers (sce also Tablc l), while this difference was found to be much larger at shorter time pcriods of stimuiation'
Frothrombin and factor X activation were also compared follou'ing ten minutes of stimulation of Since the phospholipid composition of the parienr.s platelem was confirmed to be normal,6 platelets were tesred for their ability ro expose negatively charged phospholipids upon acrivation. Expozure oi phospholipids at the outer surface of coltagen plus thrombinstimulated platelets was probed upon treatmcnt of the cells with phospholipase A1 and sphingomyelinase. under conditions at which cell lysis rernained belou, lAVo. As shown in Table 2 , patient's platelets differed markedll, from normal platelets. Aitivated platelets ll:l I conrrol subject exposed amounrs of phospholipid thar fell within rhe range prcviously published.. whereas platelets from patient M.S. had " airninirt"O exposure of glycerophospholipids and a higher expo_ sure of sphingomyelin. Since both factor i anA piothrombin activalion strongly depend on the presence of negativel), charged phosphatidl,lserine.s.e it is remark_ able that the amount of this lipid which became exposed at the outer surface of activated platelets u,as about 2[ rimes less in the patient's platelets than in cont.rol's.
. Trearment of ionophore-stimulated platelets with phospholipases for 20 minutes producia more rhan 507c breakdown of phpsphatidylsirine in normal platelets, whereas less lhan 20Vo of rhis lipid was degiaded in the patienr's plarele$ (data not iho*n;. Unfortu_ platelets with thrombin or with Ca_ionophore A23l g7 (TableI). In concordance with pr"uiou, observa_ tions,''ro platelet stimulation by thrombin produced a much smaller increase in prothrombin and factor X activarion than stimulation by collagen plus thrombin. Nevertheless, the lower activity of the patient,s plalelets in both reactions was also apparent after thrombin stimulation. A remarkable effect u,as observed when the ionophore A23 187 was used to activate platelets. Stimuiation by A23187 evoked high prothrombin-and factor X-converting activities in normal platelets, whereas no significant enhancement of both coaqula_ tion reactions occurred with ionophore-stimuiated patient's platelets. It should be menrioned that all stimulation procedures resulted in normal plarelet r 560 nately, these incubation procedures caused substantial cell lysis (up to 30%), making conclusions abour the surface exposurc ofthis lipid rather uncertain.
DISCUSSION
We have previously demonstrated that rhe abiliry of the platelet surface to promote factor X and prorhrombin activation depends on the platelet acrivarion procedure.o''o Platelet activation b1' Ca-ionophore A2318? or b), a mixture of collagen plus thrombin appeared to be much more cffective than activation b1, collagen or thrombin scparately. Several lines of evidence suggesr that the stimulatory cffect of the plarelet surface in prothrombin and factor X activation is related to the cxtent to which it exposes anionic phospholipids. Firsr, .thc ability of activated plateleu ro enhance prothrombin activation runs in parallel with their ability to cnhance factor X activation.ro Second, treatment of (activated) platelets with phospholipase A, under nonlytic conditions completely abolishes their stimulatory' effect on both coagulation factor activations.ro Third, acdvity of stimuJated platelets in prothrombin activation (and b',' e:::nsion also in factor X activation) correlates witL ihe cxtent of exposure of pbosphatidylserine at the outcr surface.{ Thc moderatcly severe blecding disorder of patient M.S. has been ascribed b1' Weiss et al6 to an isolated deficiency of platelet procoagulant activity, presum- 4. Bcvcrs EM. Comfurius P, Zwza,l RFA: Changcs in mcmbrane phospholipid distribution during platclet aoivation. Biochim Bio phys Acta 736: 57. 1983 ably due to an impaired ability of rhe platelets ro accelerare prothrombin activarion. Since thrombininduced release and activation of platelet factor V was normal,6'? a defect in the binding of coagulation factors to the plateler surface was suspecred. Miletich et al6 showed that factor Va promotes the binding of factor Xa to the platelet surface, while some unidentified platelet component ultimately limits the number of binding sites. It was subsequently demonstrated that binding of factor Xa-Va to platelers from patienr M.S. was abour 25Vo of rhe normal value, and that this was reffectcd in an impairment of the platelets to stimulatc thrombin formarion.? The unidentified plateler compo. nent was suggested to be specific for facror Va binding, and most likely represcnts a membrane protein which is partly deficient in patient M.S ?.r2 It sbould bc rqentioned, however, that binding studics with factor ' Va alone have not been reported with this patient's platelets.
The experiments presented in this report show thar platelets from M.S. are equally defective.in promoting prothrombin and factor X activation. This would exclude the possibility that the deficiency is limited ro a binding site specific for factors Va-Xa. Alrhough rhe patient's platelets can be moderately stimulated ro enhance both factor X and prorhrombin activarion, rhe extenr [o which this occurs is always much lcss than that observed *'ith stimulated control platelets. Especialli', the time course of generation of 'both procoagulant activities following platelet stimulation is much slower than normal. Incubations witb phospholipasa suggest that the decrcascd stimulatory effect of thc patient's platelets is accompanicd by a rcduced expo. sure of anionic phosphatidylserine. as compared ro normal platelets. This would point ro a defect in the mechanism by which anionic phospholipids becomc exposed at '.he ouler surface during platelet activation. Since normal platelets show the bighest procoagulant activity upon stimulation *..1i Ca-ionophore,l i[ is intriguing that this treatment is almost without effect on the patient's platelets, despite normal rclease and aggregadon. Thcrefore, the ultimate resolution of rhe defect might be revealed b1' an indepth srudy with Ca-ionophore.
